Vanguard Capital Management Files 13G, Shows 7.5% Stake in Humana

Vanguard Capital Management LLC, the investment‑advisory arm of the Vanguard Group, filed a Schedule 13G with the SEC indicating that it and related entities now hold 9,068,300 Humana Inc. (HUM) shares. The stake translates to 7.55% of the outstanding common stock, making Vanguard a significant, though passive, institutional holder.

The filing, accession number 0002100119-26-000592, lists Vanguard’s sole voting power at 1,229,538 shares and sole dispositive power over the full 9,068,300 shares. No shared voting or dispositive power was reported, confirming the group’s status as a qualified institutional investor that does not intend to influence corporate governance.

For Humana shareholders, the disclosure signals a vote of confidence from one of the world’s largest asset managers. Vanguard’s ownership is aggregated across its global platforms—including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers LLC, and Vanguard Investments Australia Ltd.—and reflects the firm’s broader strategy of holding large, diversified positions in stable, cash‑flow‑generating companies.

Humana’s stock has been under pressure, slipping 2.45% in the latest trading session to $237.17, while the broader S&P 500 rose 0.93%. The insurer’s RSI of 85 suggests the stock is nearing overbought territory, yet its 52‑week price range sits roughly at the midpoint, indicating room for movement. Vanguard’s sizable passive stake may provide a stabilizing influence as the market digests Humana’s recent earnings and its ongoing initiatives in Medicare Advantage and health‑care services.

No other investor is known to own more than 5% of Humana’s class, and the filing notes that the event requiring the statement occurred on March 31, 2026. As a routine 13G filing, it does not herald any imminent activist agenda, but it does reinforce Vanguard’s long‑term belief in Humana’s business model.